We are The Gator Nation, a diverse community dedicated to excellence in education and research and shaping a better future for Florida, the nation and the world. Our mission is to enable our students to lead and influence the next generation and beyond for economic, cultural and societal benefit.

University of Florida

New Row

Contact expert @[Full Name](fullname), @[Job Title](job_title) at @[Organization](organization) for media, speaking, professional opportunities and more.

@[Full Name](fullname) at @[Organization](organization) | Contact Form

Expert Inquiry

Open Sans

Role of Dexmedetomidine in Aneurysmal Subarachnoid Hemorrhage: A Comprehensive Scoping Review

Pregabalin for Recurrent Seizures in Critical Illness: A Promising Adjunctive Therapy, Especially for cyclic Seizures

Early vigabatrin augmenting GABA-ergic pathways in post-anoxic status epilepticus (VIGAB-STAT) phase IIa clinical trial study protocol

Dr. Katharina Busl is the chief of the Division of Neurocritical Care, professor, and associate chair of clinical operations in the Department of Neurology. She is an internationally recognized expert in neurocritical care. She has co-authored clinical guidelines for the management of subarachnoid hemorrhage, neuroprognostication guidelines for neurocritical diseases and numerous manuscripts relevant to clinical neurocritical care. Clinical interests include subarachnoid hemorrhage, neuroprognostication, her research interests center around care innovations and quality of care in neurocritical care. Specific interests include treatment of headaches in the NeuroICU, neuroprognostication and medical complications of neurocritical disease. Dr. Busl is the lead PI for BLOCK-SAH, an NIH-funded, multicenter trial to investigate pterygopalatine fossa nerve blocks for post-subarachnoid hemorrhage headaches.

Media Inquiry